- Home
- FWRG vs EIKN Comparison
FWRG vs EIKN Comparison
Compare FWRG & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FWRG | EIKN |
|---|---|---|
| Founded | 1983 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 768.7M | 631.0M |
| IPO Year | 2021 | 2026 |
Fundamental Metrics
Financial Performance| Metric | FWRG | EIKN |
|---|---|---|
| Price | $10.10 | $7.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | $20.46 | ★ $25.60 |
| AVG Volume (30 Days) | ★ 1.1M | 518.7K |
| Earning Date | 05-05-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.33 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,222,501,000.00 | N/A |
| Revenue This Year | $15.58 | N/A |
| Revenue Next Year | $12.81 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 20.34 | N/A |
| 52 Week Low | $9.88 | $7.72 |
| 52 Week High | $18.82 | $16.50 |
Technical Indicators
Market Signals| Indicator | FWRG | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 31.22 | 35.25 |
| Support Level | $10.03 | N/A |
| Resistance Level | $13.03 | $10.20 |
| Average True Range (ATR) | 0.48 | 0.78 |
| MACD | -0.08 | -0.19 |
| Stochastic Oscillator | 7.80 | 4.53 |
Price Performance
Historical ComparisonAbout FWRG First Watch Restaurant Group Inc.
First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. The company generates revenues from Restaurant sales and Franchise revenues. It generates maximum revenue from Restaurant sales.
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.